hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-04-28健康细节|平常抽血的“空”,可不是滴水不沾
- 2022-04-212013年国际抗癫痫分会抗癫痫药使用指南
- 2022-04-122013国际抗癫痫联合会抗癫痫药用指南
- 2022-04-11上海率先探索异地就医门诊费直接结算
- 2022-04-11癫痫治疗障碍仍难以克服
- 2022-04-07治疗癫痫的最低费用
- 上海率先探索异地就医门诊费直接结算
- 癫痫治疗障碍仍难以克服
- 治疗癫痫的最低费用
- FDA批准Aptiom用于治疗患者癫痫发作
- 预测癫痫患者再入院风险
- 抗癫痫药物预防新发癫痫:任重而道远
- PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 儿童癫痫的早期症状 癫痫的原因
- 心理百科:春节期间小心疾病
- UCB的Vimpat癫痫新适应症在美国获批
- 综述:癫痫持续状态诊治最新进展
- 月经性癫痫患者妊娠期癫痫控制更好
- 控制癫痫患者再次抽搐,不包括可选药物?
- 月经期间要注意 有些药物和食物不能食用
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 癫痫患者手术评估新型工具
- Radiology:利用MR颞叶癫痫病灶内侧指纹识别评价的价值
- 癫痫猝死:凶手是谁?
- Neurology:颅脑损伤增加了迟发性癫痫的风险,高损伤频率、重伤、老年人尤其是
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 脑梗死的症状是什么有这些前兆要谨慎
- 癫痫的治疗方法 中医拔罐治疗癫痫的小方法(2)
- 2016AAN:神经专家发表了有前途的专业见解
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 癫痫病治疗经费大概多少钱
- 治疗癫痫病小发烧药物
- 怎么治癫痫病最有效地啊
- 【高考注意事项】考生癫痫心脏病怎么办?如何避免?
- 20130712养生:杨红宣讲癫痫病人不能进食什么
- 世界发作日|遇到发作发作,如何紧急应对?
- 癫痫病的病因没错是什么
- 《英国医学杂志》发表文章建议将烟草依赖定义为活埋性慢病
- 癫痫病医治费用
- 应该怎么样支配癫痫病
- 昭和年间癫痫病哪里好效果好吗
- 胶质母细胞瘤能治愈吗?盘点七大前沿治疗重大突破
- 20120816cctv10健康之路:周和蔼揭秘脑部结构
- 卫材在瑞士推出新一代抗癫痫药Fycompa